
Pharma Pulse 3/26/25: Balancing Technological & Human Support in Medication Access, How PBMs’ Vertical Integration Impacts Health Care & more
The latest news for pharma industry insiders.
Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, addresses patient and prescriber expectations for digital health tools.
Although PBMs claim integration reduces costs and improves efficiency, the reality is more complicated—and often leaves patients footing the bill.
Ever since AstraZeneca Plc shocked investors in October with news its China chief was under investigation, the British pharmaceutical giant has tried to maintain a business-as-usual stance in its second-biggest market.
The use of self-care to address unmet medical needs could transform how vulnerable populations access treatment and knowledge, while reducing the burden on healthcare systems, according to a recently published study by Bayer’s Research Initiative for Self-Care Equity.
Very appreciative of Brad of BDO for taking the time to join me to cover all things tariffs. The carousel below highlights some of his thoughts during that chat - special thanks to the
Have news you want us to share in Pharma Pulse? Reach out to Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.





